Phase 3 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Double-blind, Parallel Group, Placebo-Controlled Study)

Trial Profile

Phase 3 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Double-blind, Parallel Group, Placebo-Controlled Study)

Completed
Phase of Trial: Phase III

Latest Information Update: 21 May 2016

At a glance

  • Drugs Luseogliflozin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Sponsors Taisho Pharmaceutical
  • Most Recent Events

    • 02 Oct 2013 New trial record
    • 26 Sep 2013 Results reported at 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), according to a Taisho Pharmaceutical Holdings media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top